Displaying drugs 1726 - 1750 of 3574 in total
Pramocaine
Pramocaine (also known as pramoxine or pramoxine HCI) is a topical anesthetic and antipruritic. It is used for many dermatological and anorectal/anogenital conditions including minor cuts/burns, insect bites, hives/rashes due to poison ivy exposure, hemorrhoids and other anorectal/anogenital disorders. Pramocaine is available by itself and in combination with other medications...
Approved
Matched Mixtures name: … Oto End 10 …
Carbidopa
Carbidopa presents a chemical denomination of N-amino-alpha-methyl-3-hydroxy-L-tyrosine monohydrate. It potently inhibits aromatic amino acid decarboxylase (DDC) and due to its chemical properties, it does not cross the blood-brain barrier. Due to its activity, carbidopa is always administered concomitantly with levodopa. An individual formulation containing solely carbidopa was generated to treat...
Approved
Matched Mixtures name: … Sinemet 100/10 ... Pro-lecarb-100/10 - Tab …
Sulfamethoxazole
Sulfamethoxazole is a bacteriostatic sulfonamide antibiotic that interferes with folic acid synthesis in susceptible bacteria. It is generally given in combination with trimethoprim, which inhibits a sequential step in bacterial folic acid synthesis - these agents work synergistically to block two consecutive steps in the biosynthesis of nucleic acids and...
Approved
Matched Mixtures name: … SEPTRIN IV 5 ML 10 AMPUL …
Synthetic camphor
Approved
Experimental
Matched Mixtures name: … Menthol 10 percent plus Camphor 4 percent …
Pramlintide
Pramlintide is a relatively new adjunct treatment for diabetes (both type 1 and 2), developed by Amylin Pharmaceuticals. It is derived from amylin, a hormone that is released into the bloodstream, in a similar pattern as insulin, after a meal. Like insulin, amylin is deficient in individuals with diabetes.
Approved
Investigational
Matched Iupac: … 10S,13S,16S,19R)-16-(carbamoylmethyl)-19-[(2S)-2,6-diaminohexanamido]-7,13-bis[(1R)-1-hydroxyethyl]-10 …
Aminolevulinic acid
A compound produced from succinyl-CoA and glycine as an intermediate in heme synthesis. It is used as a photochemotherapy for actinic keratosis. [PubChem]
Approved
Dextromethorphan
Dextromethorphan is a levorphanol derivative and codeine analog commonly used as a cough suppressant and also a drug of abuse. Although similar in structure to other opioids, it has minimal interaction with opioid receptors. Dextromethorphan was granted FDA approval before 3 December 1957.[A215412,L14997]
Approved
Matched Salts cas: … 125-69-9 …
Matched Mixtures name: … DAYCOLD-HOT 500/10/15/100 MG SAŞE ,10 SAŞE ... Ornade DM 10 Liq ... DAYCOLD-HOT 500/10/15/100 MG SAŞE,6 SAŞE …
Matched Mixtures name: … DAYCOLD-HOT 500/10/15/100 MG SAŞE ,10 SAŞE ... Ornade DM 10 Liq ... DAYCOLD-HOT 500/10/15/100 MG SAŞE,6 SAŞE …
Triclosan
An aromatic ether that is phenol which is substituted at C-5 by a chloro group and at C-2 by a 2,4-dichlorophenoxy group. It is widely used as a preservative and antimicrobial agent in personal care products such as soaps, skin creams, toothpaste and deodorants as well as in household items...
Approved
Investigational
Matched Products: … Mc-10 Antiseptic Hand Lotion 0.3% …
3-(10-methyl-9-anthryl)propanoic acid
Experimental
Matched Synonyms: … 3-(10-methyl-9-anthryl)propionic acid ... 3-(10-METHYL-ANTHRACEN-9-YL)-PROPIONIC ACID …
Matched Name: … 3-(10-methyl-9-anthryl)propanoic acid …
Matched Iupac: … 3-(10-methylanthracen-9-yl)propanoic acid …
Matched Name: … 3-(10-methyl-9-anthryl)propanoic acid …
Matched Iupac: … 3-(10-methylanthracen-9-yl)propanoic acid …
CXA-10
CXA-10 is under investigation in clinical trial NCT03422510 (FIRSTx - A Study of Oral CXA-10 in Primary Focal Segmental Glomerulosclerosis (FSGS)).
Investigational
Matched Synonyms: … 10-nitro-9(E)-octadec-9-enoic acid …
Matched Name: … CXA-10 …
Matched Iupac: … (9E)-10-nitrooctadec-9-enoic acid …
Matched Description: … CXA-10 is under investigation in clinical trial NCT03422510 (FIRSTx - A Study of Oral CXA-10 in Primary …
Matched Name: … CXA-10 …
Matched Iupac: … (9E)-10-nitrooctadec-9-enoic acid …
Matched Description: … CXA-10 is under investigation in clinical trial NCT03422510 (FIRSTx - A Study of Oral CXA-10 in Primary …
DTX-101
DTX-101 is an investigational gene therapy consisting of an adeno-associated virus serotype Rh10 vector encoding the human Factor Ix gene. It was previously investigated for the treatment of hemophilia B; however, the clinical development of DTX-101 was discontinued.
Investigational
Matched Synonyms: … DTX 101 …
Matched Name: … DTX-101 …
Matched Description: … DTX-101 is an investigational gene therapy consisting of an adeno-associated virus serotype Rh10 vector ... previously investigated for the treatment of hemophilia B; however, the clinical development of DTX-101 …
Matched Name: … DTX-101 …
Matched Description: … DTX-101 is an investigational gene therapy consisting of an adeno-associated virus serotype Rh10 vector ... previously investigated for the treatment of hemophilia B; however, the clinical development of DTX-101 …
TTI-101
Investigational
Matched Synonyms: … Stat3 inhibitor c188-9 ... Stat3 inhibitor tti-101 …
Matched Name: … TTI-101 …
Matched Name: … TTI-101 …
FB-101
FB-101 is a c-Abl inhibitor. Developed by 1st Biotherapeutics, it is being investigated for the treatment of neurological disorders, such as Parkinson's Disease and amyotrophic lateral sclerosis (ALS).
Experimental
Investigational
Matched Synonyms: … FB 101 …
Matched Name: … FB-101 …
Matched Description: … FB-101 is a c-Abl inhibitor. …
Matched Name: … FB-101 …
Matched Description: … FB-101 is a c-Abl inhibitor. …
ACT-101
ACT-101 is a recombinant human alpha-fetoprotein or rhAFP.
Investigational
Matched Synonyms: … ACT 101 …
Matched Name: … ACT-101 …
Matched Description: … ACT-101 is a recombinant human alpha-fetoprotein or rhAFP. …
Matched Name: … ACT-101 …
Matched Description: … ACT-101 is a recombinant human alpha-fetoprotein or rhAFP. …
EGT-101
EGT-101 is an adeno-associated viral vector serotype 9 (AAV9) vector-based gene therapy consisting of the human sulfamidase (SGSH) transgene. Developed by Esteve Pharmaceuticals, it is being investigated for Sanfilippo syndrome type A.
Investigational
Matched Synonyms: … EGT 101 …
Matched Name: … EGT-101 …
Matched Description: … EGT-101 is an adeno-associated viral vector serotype 9 (AAV9) vector-based gene therapy consisting of …
Matched Name: … EGT-101 …
Matched Description: … EGT-101 is an adeno-associated viral vector serotype 9 (AAV9) vector-based gene therapy consisting of …
9-(2-carboxyethyl)-10-methylanthracene endoperoxide
Experimental
Matched Synonyms: … [2'-CARBOXYLETHYL]-10-METHYL-ANTHRACENE ENDOPEROXIDE …
Matched Name: … 9-(2-carboxyethyl)-10-methylanthracene endoperoxide …
Matched Name: … 9-(2-carboxyethyl)-10-methylanthracene endoperoxide …
Interleukin-10
Interleukin-10 has been used in trials studying the prevention and treatment of Vasculitis, Pancreatitis, Bile Duct Diseases, Pancreatic Diseases, and Gallbladder Diseases, among others.
Investigational
Matched Synonyms: … IL-10 ... IL-10 (nonglycosylated) …
Matched Name: … Interleukin-10 …
Matched Description: … Interleukin-10 has been used in trials studying the prevention and treatment of Vasculitis, Pancreatitis …
Matched Name: … Interleukin-10 …
Matched Description: … Interleukin-10 has been used in trials studying the prevention and treatment of Vasculitis, Pancreatitis …
AMP-101
AMP-101 is a gene therapy comprising an adeno-associated virus type 9 (AAV9) vector encoding the human Dok-7 protein. It is under investigation for the treatment of Dok-7-associated myasthenia.
Investigational
Matched Synonyms: … Adeno-associated virus serotype 9 vector encoding the Dok7 protein …
Matched Name: … AMP-101 …
Matched Description: … AMP-101 is a gene therapy comprising an adeno-associated virus type 9 (AAV9) vector encoding the human …
Matched Name: … AMP-101 …
Matched Description: … AMP-101 is a gene therapy comprising an adeno-associated virus type 9 (AAV9) vector encoding the human …
AMT-101
AMT-101 is a recombinant human interleukin-10 fusion protein.
Investigational
Matched Synonyms: … Recombinant human interleukin-10 fusion protein …
Matched Name: … AMT-101 …
Matched Description: … AMT-101 is a recombinant human interleukin-10 fusion protein. …
Matched Name: … AMT-101 …
Matched Description: … AMT-101 is a recombinant human interleukin-10 fusion protein. …
Kisspeptin-10
Kisspeptin-10 is under investigation in clinical trial NCT03771326 (KP-10 and Insulin Secretion in Men).
Investigational
Matched Synonyms: … Kisspeptin-10 (human) …
Matched Name: … Kisspeptin-10 …
Matched Description: … Kisspeptin-10 is under investigation in clinical trial NCT03771326 (KP-10 and Insulin Secretion in Men …
Matched Name: … Kisspeptin-10 …
Matched Description: … Kisspeptin-10 is under investigation in clinical trial NCT03771326 (KP-10 and Insulin Secretion in Men …
DYN-101
DYN-101 is an antisense product candidate designed to reduce the expression of dynamin 2 protein.
Investigational
Matched Synonyms: … DYN 101 …
Matched Name: … DYN-101 …
Matched Description: … DYN-101 is an antisense product candidate designed to reduce the expression of dynamin 2 protein. …
Matched Name: … DYN-101 …
Matched Description: … DYN-101 is an antisense product candidate designed to reduce the expression of dynamin 2 protein. …
TSHA-101
Investigational
Matched Synonyms: … adeno-associated viral vector serotype 9 (AAV9) carrying both HEXA and HEXB …
Matched Name: … TSHA-101 …
Matched Name: … TSHA-101 …
9-Aminophenanthrene
Experimental
Matched Synonyms: … 9-phenanthrenamine ... 9-phenanthrylamine ... phenanthren-9-amine …
Matched Name: … 9-Aminophenanthrene …
Matched Iupac: … phenanthren-9-amine …
Matched Name: … 9-Aminophenanthrene …
Matched Iupac: … phenanthren-9-amine …
AMY-101
AMY-101, also known as compstatin 40, is a peptidic inhibitor of the central complement component C3. AMY-101 is under investigation in clinical trial NCT03694444 (A Study of the C3 Complement Inhibitor AMY-101 in Adults With Gingivitis).
Investigational
Matched Synonyms: … AMY 101 …
Matched Name: … AMY-101 …
Matched Iupac: … carbamimidamidopropyl)-4-{[(1S,2S)-1-carbamoyl-2-methylbutyl](methyl)carbamoyl}-25-(2-carbamoylethyl)-10 …
Matched Description: … AMY-101 in Adults With Gingivitis). ... AMY-101, also known as compstatin 40, is a peptidic inhibitor of the central complement component C3. ... AMY-101 is under investigation in clinical trial NCT03694444 (A Study of the C3 Complement Inhibitor …
Matched Name: … AMY-101 …
Matched Iupac: … carbamimidamidopropyl)-4-{[(1S,2S)-1-carbamoyl-2-methylbutyl](methyl)carbamoyl}-25-(2-carbamoylethyl)-10 …
Matched Description: … AMY-101 in Adults With Gingivitis). ... AMY-101, also known as compstatin 40, is a peptidic inhibitor of the central complement component C3. ... AMY-101 is under investigation in clinical trial NCT03694444 (A Study of the C3 Complement Inhibitor …
Displaying drugs 1726 - 1750 of 3574 in total